Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd

<< Previous

Bullboard Posts

Next >>

Post by cool888on Dec 27, 2020 6:34pm

190 Views

Post# 32185965

$RVV $RVVTF - Psychedelic highlights | December 21 – 24

Rock And Roll Psychedelic Art GIF by Grande Dame - Find & Share on GIPHY

Psychedelic highlights | December 21 – 24

Here is a summary of the news from the last week in the psychedelics market. The value of the psychedelics market is more than $100 billion according to Cannacord most recent report.

Psychedelic market value by company

Last week performance

COMPANY	TICKER	DEC 18	WEEK %
Trip Therapeutics	TRYP	$0.74	+ 4.2 %
Revive Therapeutics	RVV	$0.69	+ 00 %
Compass	CMPS	$55.03	– 3.5 %
M2Bio Sciences	WUHN	$0.38	– 5 %
MindMed	MMED	$3.85	– 14 %
Mind Cure	MCUR	$0.70	– 15.6 %
Field Trip	FTRP	$4.34	– 18.4 %
Psyched Wellness	PSYC	$0.28	– 20 %
Red Light Hollands	TRIP	$0.29	– 20.5 %
Numinus	NUMI	$1.25	– 31 %